A migraine drug could be offered to sufferers of facial flushing after a study found it significantly reduced symptoms.
Around one in 20 people in the UK have the skin condition rosacea, which causes a hot and red face as well as spots.
Rosacea cannot be cured but antibiotics and prescription creams can improve symptoms.
In the US study, 30 adults with severe rosacea were given the migraine drug erenumab.
Rosacea, a condition that causes hot and red face (left before treatment and right after laser surgery) (File)
File photo. The migraine drug erenumab could be used to help alleviate symptoms of rosacea
The jab blocks the effect of a protein which is linked to the debilitating headaches and nausea of migraine.
Published last week, the research found rosacea patients taking erenumab saw a significant reduction in their symptoms.
Those most affected by the condition saw an 80 per cent decline in severe to extreme flushing within days of beginning the treatment.
Study author Dr John Barbieri, a consultant dermatologist at Brigham and Women’s Hospital in Boston, said the results showed ‘promising potential’ for rosacea patients.
Related articles:
Related suggestion:
Demand for China's fast fashion boosts global air freight cargoTiny toothChinese companies retain 2nd place on Hurun Top 500Boom in travel to 'ice city' Harbin spurs sales of cranberry productsBoom in travel to 'ice city' Harbin spurs sales of cranberry productsChina's current account surplus remains in reasonable rangeXi Sends Congratulatory Letter to ChinaChina's deepState energy firms turn to renewables abroadChina launches new satellite for space environment survey
3.251s , 6508.5625 kb
Copyright © 2024 Powered by Migraine drug could be offered to facial flush sufferers after success in trial ,Global Glossary news portal